Your browser doesn't support javascript.
loading
Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2.
Seo, Yohan; Mun, Chin Hee; Park, So-Hyeon; Jeon, Dongkyu; Kim, Su Jeong; Yoon, Taejun; Ko, Eunhee; Jo, Sungwoo; Park, Yong-Beom; Namkung, Wan; Lee, Sang-Won.
Afiliação
  • Seo Y; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Korea.
  • Mun CH; New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Korea.
  • Park SH; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Jeon D; Graduate Program of Industrial Pharmaceutical Science, Yonsei University, Incheon 21983, Korea.
  • Kim SJ; College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Korea.
  • Yoon T; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Ko E; BK21 Plus Project, Department of Medical Sciences, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Jo S; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Park YB; BK21 Plus Project, Department of Medical Sciences, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Namkung W; Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea.
  • Lee SW; BK21 Plus Project, Department of Medical Sciences, Yonsei University College of Medicine, Seoul 03722, Korea.
Int J Mol Sci ; 21(14)2020 Jul 14.
Article em En | MEDLINE | ID: mdl-32674502

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Receptor PAR-2 / Taninos Hidrolisáveis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / Receptor PAR-2 / Taninos Hidrolisáveis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2020 Tipo de documento: Article